# Traferox Technologies, Inc.

- Location (FDA's records): Mississauga, CA
- FDA decisions: 5 (2024–2026): 4 510(k) clearances and 1 original PMA approval
- Product codes: KDN (3), MSB (1), PHO (1)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Pragonix Technologies: 2 (https://510kreport.com/company/pragonix-technologies)
- Xvivo Perfusion AB: 1 (https://510kreport.com/company/xvivo-perfusion)
- Paragonix Technologies, Inc.: 1 (https://510kreport.com/company/paragonix-technologies)

## Its most-cited devices
- K240650: LungProtect (2024), cited by 1

## Recent decisions
- K261913: X°Port Heart Preservation System (Sep 16, 2026)
- P250025: TorEx Lung Perfusion System (Jul 15, 2026)
- K260456: VI°Port™ Liver Preservation System (Jun 1, 2026)
- K243870: X°Port Lung Preservation System; X°Port Lung Preservation Solution (May 1, 2025)
- K240650: LungProtect (Nov 26, 2024)

Source page: https://510kreport.com/company/traferox-technologies